Q4 2026 Piramal Pharma Ltd Earnings Call Transcript
Key Points
- Piramal Pharma Ltd (BOM:543635) reported a strong financial performance for the year, with a consolidated net profit of INR 1,506 crores, a threefold increase year-on-year.
- The company's total Assets Under Management (AUM) grew by 25% year-on-year, surpassing the 1 lakh crore mark.
- Retail business AUM grew by 33% year-on-year, now forming 85% of the total AUM, showcasing a successful transition from wholesale to retail.
- The company achieved a significant improvement in asset quality, with zero Non-Performing Assets (NPAs) in the wholesale 2.0 book.
- Piramal Pharma Ltd (BOM:543635) received upgrades in both domestic and foreign credit ratings, with domestic long-term debt now rated AA+ by all three leading credit agencies.
- Geopolitical disruptions in the Gulf have created a volatile global macroeconomic environment, posing potential risks to the company's operations.
- The legacy book, although reduced significantly, still poses a challenge as it needs to be completely phased out.
- The company faces potential risks from the ongoing conflict in the Middle East, particularly in sensitive sectors like travel, logistics, and textiles.
- Despite the strong financial performance, the company has a high cost of borrowing, which it aims to reduce over the next three years.
- The expansion of the branch network could lead to increased operational expenses, potentially impacting the OpEx to AUM ratio.
Ladies and Gentlemen, good day and welcome to the Q4 and Annual financial year 2026 Earnings Conference Call, hosted by Piramal Finance Limited.
As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing then 0 on your touchtone phone.
The reserves materials are available on exchanges and the company's website, and you may refer to them during the discussion.
Please note that today's discussion may include certain forward-looking statements, which must be viewed in conjunction with the risks and uncertainties that the company faces. These statements are based on management's current expectations and are subject to uncertainty and changes.
On the call today we have with us Mr. Anand Piramal, Executive Chairman, Mr. Jairam Sridharan, Managing Director and CEO, Mr. Rupen Jhaveri, Group President, Mr. Yesh Nadkarni, CEO, Wholesale Lending, Mr. Vikash Singla, CFO, and Mr. Ravi
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
